Bourgeois-Nicolaos Nadège, Massias Laurent, Couson Brigitte, Butel Marie-José, Andremont Antoine, Doucet-Populaire Florence
Laboratoire de Bacteriologie, Hopital Bichat Claude Bernard, Paris, 75018, France.
J Infect Dis. 2007 May 15;195(10):1480-8. doi: 10.1086/513876. Epub 2007 Apr 3.
The emergence of resistance to antibiotics in vivo, particularly in commensal, potentially pathogenic bacteria, is a factor that is key to the future of antibiotics. To better document the circumstances favoring the emergence of resistance to linezolid (the first of a new class of antibiotics, the oxazolidinones), we modeled the effect of different regimens of linezolid on Enterococcus faecalis in gnotobiotic mice.
We studied the rate of emergence of linezolid-resistant E. faecalis mutants in the digestive tract of gnotobiotic mice monoassociated with linezolid-susceptible E. faecalis and fed with water containing linezolid (0.5, 0.05, or 0.005 g/L). 23S Ribosomal RNA (rRNA) mutations were characterized by sequencing each of the 4 copies of the rRNA genes individually.
Mutants were readily obtained in vivo, but the frequencies, persistence, and type of mutants were all dependent on the linezolid regimen. Mutations conferring resistance, either the G2505A or G2576U mutation, were present in domain V of the 23S rRNA gene of all resistant isolates. Levels of resistance increased with the number of mutated copies of the 23S rRNA gene and with duration of exposure.
The antibiotic dose appears to be critical in the dynamics and molecular basis of resistance.
体内对抗生素产生耐药性,尤其是在共生的潜在病原菌中产生耐药性,是影响抗生素未来发展的关键因素。为了更好地记录有利于利奈唑胺(一类新型抗生素恶唑烷酮中的首个药物)耐药性出现的情况,我们在悉生小鼠中模拟了不同利奈唑胺给药方案对粪肠球菌的影响。
我们研究了在与对利奈唑胺敏感的粪肠球菌单联的悉生小鼠消化道中,用含利奈唑胺(0.5、0.05或0.005 g/L)的水喂养时,耐利奈唑胺粪肠球菌突变体的出现率。通过对4个rRNA基因拷贝逐一进行测序来鉴定23S核糖体RNA(rRNA)突变。
突变体很容易在体内获得,但突变体的频率、持续性和类型均取决于利奈唑胺给药方案。赋予耐药性的突变,即G2505A或G2576U突变,存在于所有耐药分离株的23S rRNA基因的V结构域中。耐药水平随着23S rRNA基因突变拷贝数的增加和暴露持续时间的延长而升高。
抗生素剂量在耐药性的动态变化和分子基础中似乎至关重要。